Alloreactivity of ex vivo-expanded T cells is correlated with expansion and CD4/CD8 ratio

Cytotherapy

Volumn 10, Issue 3, 2008, Pages 275-288

  Mercier Letondal, P ^a,b,c   Montcuquet, N ^a,b,c   Sauce, D ^a,b,c   Certoux, J M ^a,b,c   Jeanningros, S ^a,b,c   Ferrand, C ^a,b,c   Bonyhadi, M ^d   Tiberghien, P ^a,b,c   Robinet, E ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d INVITROGEN CORPORATION   (United States)

Author keywords

Alloreactivity; Gene transfer; Interleukin 15; Interleukin 2; Interleukin 7; T cell

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 7; MONOCLONAL ANTIBODY CD28; MONOCLONAL ANTIBODY CD3; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN;

ADULT; ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4 CD8 RATIO; CELL EXPANSION; CONTROLLED STUDY; GENE TRANSFER; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE CULTURE; MALE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; T LYMPHOCYTE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; GENETIC TRANSDUCTION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MIXED LYMPHOCYTE CULTURE;

ADULT; ANTIGENS, CD28; ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD8; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; INTERLEUKIN-15; INTERLEUKIN-2; INTERLEUKIN-7; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; PHENOTYPE; T-LYMPHOCYTES; TRANSDUCTION, GENETIC;

EID: 42449098555     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240801927032     Document Type: Article

References (59)

1. Tiberghien, P., Ferrand, C. and Lioure, B. (2001) Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft. Blood, 97, pp. 63-72.
2. Robinet, E., Certoux, JM and Ferrand, C. (1998) A closed culture system for the ex vivo transduction and expansion of human T lymphocytes. J Hematother, 7, pp. 205-215.
3. Contassot, E., Murphy, W. and Angonin, R. (1998) In vivo alloreactive potential of ex vivo-expanded primary T lymphocytes. Transplantation, 65, pp. 1365-1370.
4. Sauce, D., Tonnelier, N. and Duperrier, A. (2002) Influence of ex vivo expansion and retrovirus-mediated gene transfer on primary T lymphocyte phenotype and functions. J Hematother Stem Cell Res, 11, pp. 929-940.
5. Drobyski, WR, Majewski, D. and Ozker, K. (1998) Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment. J Immunol, 161, pp. 2610-2619.
6. Weijtens, M., van Spronsen, A. and Hagenbeek, A. (2002) Reduced graft-versus-host disease-inducing capacity of T cells after activation, culturing, and magnetic cell sorting selection in an allogeneic bone marrow transplantation model in rats. Hum Gene Ther, 13, pp. 187-198.
7. Duarte, RF, Chen, FE and Lowdell, MW (2002) Functional impairment of human T-lymphocytes following PHA-induced expansion and retroviral transduction: Implications for gene therapy. Gene Ther, 9, pp. 1359-1368.
8. Marktel, S., Magnani, Z. and Ciceri, F. (2003) Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantation. Blood, 101, pp. 1290-1298.
9. Lamana, ML, Bueren, JA and Vicario, JL (2004) Functional and phenotypic variations in human T cells subjected to retroviral-mediated gene transfer. Gene Ther, 11, pp. 474-482.
10. Sauce, D., Bodinier, M. and Garin, M. (2002) Retrovirus-mediated gene transfer in primary T lymphocytes impairs their anti-Epstein-Barr virus potential through both culture-dependent and selection process-dependent mechanisms. Blood, 99, pp. 1165-1173.
11. Carlens, S., Liu, D. and Ringden, O. (2002) Cytolytic T cell reactivity to Epstein-Barr virus is lost during in vitro T cell expansion. J Hematother Stem Cell Res, 11, pp. 669-674.
12. Hedfors, IA and Brinchmann, JE. (2004) Polyclonal T-cell activation protocol stimulates preferential expansion of EBV-specific T-cell clones in vitro. Cancer Immunol Immunother, 53, pp. 439-444.
13. Ferrand, C., Robinet, E. and Contassot, E. (2000) Retrovirus-mediated gene transfer in primary T lymphocytes: Influence of the transduction/ selection process and of ex vivo expansion on the T cell receptor beta chain hypervariable region repertoire. Hum Gene Ther, 11, pp. 1151-1164.
14. Coito, S., Sauce, D. and Duperrier, A. (2004) Retrovirus-mediated gene transfer in human primary T lymphocytes induces an activation- and transduction/selection-dependent TCR-B variable chain repertoire skewing of gene-modified cells. Stem Cells Dev, 13, pp. 71-81.
15. Bello-Fernandez, C., Stasakova, J. and Renner, A. (2003) Retrovirus-mediated IL-7 expression in leukemic dendritic cells generated from primary acute myelogenous leukemias enhances their functional properties. Blood, 101, pp. 2184-2190.
16. Duarte, RF, Mufti, GJ and Madrigal, JA. (2005) The effect of interleukin-7 on the alloreactivity of human T cells depends on the timing of its administration in relation to the allostimulus. Bone Marrow Transplant, 35, pp. 733-734.
17. Rowshani, AT, Uss, A. and Yong, SL (2004) Effects of CD25 monoclonal antibody on proliferative and effector functions of alloactivated human T cells in vitro. Eur J Immunol, 34, pp. 882-899.
18. Westermann, J., Aicher, A. and Qin, Z. (1998) Retroviral interleukin-7 gene transfer into human dendritic cells enhances T cell activation. Gene Ther, 5, pp. 264-271.
19. Sinha, ML, Fry, TJ and Fowler, DH (2002) Interleukin 7 worsens graft-versus-host disease. Blood, 100, pp. 2642-2649.
20. Blaser, BW, Roychowdhury, S. and Kim, DJ (2005) Donor-derived IL-15 is critical for acute allogeneic graft-versus-host disease. Blood, 105, pp. 894-901.
21. Roychowdhury, S., Blaser, BW and Freud, AG (2005) IL-15 but not IL-2 rapidly induces lethal xenogeneic graft-versus-host disease. Blood, 106, pp. 2433-2435.
22. Mavilio, F., Ferrari, G. and Rossini, S. (1994) Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. Blood, 83, pp. 1988-1997.
23. Bondanza, A., Valtolina, V. and Magnani, Z. (2006) Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes. Blood, 107, pp. 1828-1836.
24. Cooke, KR, Kobzik, L. and Martin, TR (1996) An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation. I. The roles of minor H antigens and endotoxin. Blood, 88, pp. 3230-3239.
25. + naive T cells: Potential for adoptive immunotherapy and allodepletion. Blood, 104, pp. 2403-2409.
26. low subset. Eur J Immunol, 34, pp. 408-417.
27. + T cells expressing the lymph node-homing chemokine receptor CCR7 increases incidence and severity of acute graft-versus-host disease in patients undergoing allogeneic stem cell transplantation for hematological malignancy. Leukemia, 20, pp. 1557-1565.
28. Chen, BJ, Deoliveira, D. and Cui, X. (2007) Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse. Blood, 109, pp. 3115-3123.
29. + T cells do not induce graft-versus-host disease. J Clin Invest, 112, pp. 101-108.
30. - memory T cells without graft-versus-host disease. Blood, 103, pp. 1534-1541.
31. + T cells vary in differentiation phenotype in different persistent virus infections. Nat Med, 8, pp. 379-385.
32. Sallusto, F., Lenig, D. and Forster, R. (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature, 401, pp. 708-712.
33. + T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: Potential for adoptive T cell immunotherapy. Clin Immunol, 119, pp. 21-31.
34. Asano, Y., Komuro, T. and Tada, T. (1990) Synergistic T-T cell interaction present in alloreactivity: Determination of 'MLR helper' T cell subsets. Int Immunol, 2, pp. 1203-1211.
35. + T cells in vitro. Transplantation, 78, pp. 815-824.
36. van Rijn, RS, Simonetti, ER and Hagenbeek, A. (2007) Quantitative assessment of human T lymphocytes in RAG2(-/-)gammac(-/-) mice: The impact of ex vivo manipulation on in vivo functionality. Exp Hematol, 35, pp. 117-127.
37. Tiberghien, P. (2001) Use of suicide gene-expressing donor T-cells to control alloreactivity after haematopoietic stem cell transplantation. J Intern Med, 249, pp. 369-377.
38. Bonini, C., Ferrari, G. and Verzeletti, S. (1997) HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science, 276, pp. 1719-1724.
39. Reiser, JB, Darnault, C. and Guimezanes, A. (2000) Crystal structure of a T cell receptor bound to an allogeneic MHC molecule. Nat Immunol, 1, pp. 291-297.
40. Hennecke, J. and Wiley, DC. (2002) Structure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): Insight into TCR cross-restriction and alloreactivity. J Exp Med, 195, pp. 571-581.
41. Archbold, JK, Macdonald, WA and Miles, JJ (2006) Alloreactivity between disparate cognate and allogeneic pMHC-I complexes is the result of highly focused, peptide-dependent structural mimicry. J Biol Chem, 281, pp. 34324-34332.
42. + T cells. J Clin Invest, 115, pp. 1616-1626.
43. + T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci USA, 102, pp. 9571-9576.
44. Kalamasz, D., Long, SA and Taniguchi, R. (2004) Optimization of human T-cell expansion ex vivo using magnetic beads conjugated with anti-CD3 and anti-CD28 antibodies. J Immunother, 27, pp. 405-418.
45. Demirci, G., Gao, W. and Zheng, XX (2002) On CD28/CD40 ligand costimulation, common gamma-chain signals, and the alloimmune response. J Immunol, 168, pp. 4382-4390.
46. Lin, SJ, Cheng, PJ and Hsiao, SS. (2006) Effect of interleukin-15 on effector and regulatory function of anti-CD3/anti-CD28-stimulated CD4(+) T cells. Bone Marrow Transplant, 37, pp. 881-887.
47. Moretta, A., Accolla, RS and Cerottini, JC. (1982) IL-2-mediated T cell proliferation in humans is blocked by a monoclonal antibody directed against monomorphic determinants of HLA-DR antigens. J Exp Med, 155, pp. 599-604.
48. Chouaib, S., Bensussan, A. and Termijtelen, AM (1988) Allogeneic T cell activation triggering by MHC class I antigens. J Immunol, 141, pp. 423-429.
49. Villarino, AV, Tato, CM and Stumhofer, JS (2007) Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals. J Exp Med, 204, pp. 65-71.
50. Montes, M., Rufer, N. and Appay, V. (2005) Optimum in vitro expansion of human antigen-specific CD8 T cells for adoptive transfer therapy. Clin Exp Immunol, 142, pp. 292-302.
51. Lin, SJ, Cheng, PJ and Yan, DC (2006) Effect of interleukin-15 on alloreactivity in umbilical cord blood. Transpl Immunol, 16, pp. 112-116.
52. Liu, S., Riley, J. and Rosenberg, S. (2006) Comparison of common gamma-chain cytokines, interleukin-2, interleukin-7, and interleukin-15 for the in vitro generation of human tumor-reactive T lymphocytes for adoptive cell transfer therapy. J Immunother, 29, pp. 284-293.
53. + T cell differentiation: Contrasting pictures in blood and tonsillar lymphoid tissue. J Infect Dis, 195, pp. 268-278.
54. Delon, J., Gregoire, C. and Malissen, B. (1998) CD8 expression allows T cell signaling by monomeric peptide-MHC complexes. Immunity, 9, pp. 467-473.
55. Arcaro, A., Gregoire, C. and Bakker, TR (2001) CD8beta endows CD8 with efficient coreceptor function by coupling T cell receptor/CD3 to raft-associated CD8/p56(lck) complexes. J Exp Med, 194, pp. 1485-1495.
56. Doucey, MA, Legler, DF and Boucheron, N. (2001) CTL activation is induced by cross-linking of TCR/MHC-peptide-CD8/p56lck adducts in rafts. Eur J Immunol, 31, pp. 1561-1570.
57. Pollok, KE, van der Loo, JC and Cooper, RJ (1999) Costimulation of transduced T lymphocytes via T cell receptor-CD3 complex and CD28 leads to increased transcription of integrated retrovirus. Hum Gene Ther, 10, pp. 2221-2236.
58. Rettig, MP, Ritchey, JK and Meyerrose, TE (2003) Transduction and selection of human T cells with novel CD34/thymidine kinase chimeric suicide genes for the treatment of graft-versus-host disease. Mol Ther, 8, pp. 29-41.
59. Sauce, D., Rufer, N. and Mercier, P. (2003) Retrovirus-mediated gene transfer in polyclonal T cells results in lower apoptosis and enhanced ex vivo cell expansion of CMV-reactive CD8 T cells as compared with EBV-reactive CD8 T cells. Blood, 102, pp. 1241-1248.